Longaeva Partners »

Charles River Laboratories shares owned by Longaeva Partners

Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Charles River Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Charles River Laboratories held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Charles River Laboratories by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.3M 37k 172.50

More positions owned by Longaeva Partners

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Boston Scientific Corporation Call Option (BSX)
Bank of America Corporation (BAC)
NVIDIA Corporation Call Option (NVDA)
PNC Financial Services (PNC)
Key (KEY)
Goldman Sachs (GS)
Morgan Stanley Com New (MS)
Minimed Group
Citizens Financial (CFG)
Evercore Class A (EVR)
Mastercard Incorporated Cl A (MA)
Msci (MSCI)
S&p Global (SPGI)
Us Bancorp Com New (USB)

View all positions for Longaeva Partners

Top funds holding Charles River Laboratories

Vanguard Group
BlackRock
Vanguard Capital Management
Invesco
Vanguard Portfolio Management
Harris Associates L.P
Allspring Global Investments Holdings
State Street Corporation
Wellington Management Company
FMR
Dimensional Fund Advisors
Ariel Investments
Geode Capital Management
Citadel Advisors
Bank of America Corporation

View all funds holding Charles River Laboratories